Problems with drug and alcohol use are at least as prevalent for persons with disabilities as the general population, yet treatment for these problems is much more difficult to access for persons with disabilities. This study examined statewide data on Oregon's state-funded chemical dependency treatment and linked it with Medicaid eligibility for SSI for multiple years during the past decade. Findings indicate that persons with Medicaid disability eligibility codes access treatment at approximately one-half the rate of other Medicaid eligible subpopulations. Treatment effectiveness as determined by multiple indicators demonstrate that treatment for persons with disabilities is as effective or almost as effective as for other subpopulations. Nature of treatment differs, with greater likelihood of methadone treatment for persons with disabilities. These findings reflect difficulty in accessing services or under-utilization of services. Interpretation of these findings is supplemented through information gained through interviews with agency personnel, treatment providers, and persons with disabilities. Implications for public policy around access to treatment are outlined. See www.healthwellness.org
Learning Objectives: 1. Describe the likelihood of drug and alcohol treatment access for persons with disabilities 2. Identify possible barriers to treatment 3. Describe public policy implications for expanding treatment access
Keywords: Barriers to Care, Drug Abuse Treatment
Presenting author's disclosure statement:
Organization/institution whose products or services will be discussed: None
Disclosure not received
Relationship: Not Received.